- Notification that Annual Report will be submitted late (NTN 10K)
May 03 2011 - 5:21PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 12b-25
Commission File Number: 1-35069
CUSIP Number: 584949101
NOTIFICATION OF LATE FILING
|
|
|
(Check One):
|
|
þ
Form 10-K
o
Form 20-F
o
Form 11-K
o
Form 10-Q
o
Form 10-D
o
Form N-SAR
o
Form N-CSR
|
|
|
|
|
|
For Period Ended:
December 31, 2010
|
|
|
|
|
|
o
Transition Report on Form 10-K
|
|
|
|
|
|
o
Transition Report on Form 20-F
|
|
|
|
|
|
o
Transition Report on Form 11-K
|
|
|
|
|
|
o
Transition Report on Form 10-Q
|
|
|
|
|
|
o
Transition Report on Form N-SAR
|
|
|
|
|
|
For the Transition Period Ended:
|
Nothing in this form shall be construed to imply that the Commission has verified any information contained herein.
If the notification relates to a portion of the filing checked above, identify the Item(s) to
which the notification relates:
PART I
REGISTRANT INFORMATION
|
|
|
MedQuist Holdings Inc.
Full Name of Registrant
|
|
|
|
|
|
Former Name if Applicable
|
|
|
|
|
|
9009 Carothers Parkway, Suite C-2
Address of Principal Executive Office (
Street and Number
)
|
|
|
|
|
|
Franklin, TN 37067
City, State and Zip Code
|
|
|
PART II
RULE 12b-25 (b) AND (c)
If the subject report could not be filed without unreasonable effort or expense and the registrant
seeks relief pursuant to Rule 12b-25(b), the following should be completed. (Check box if
appropriate.)
|
|
|
|
|
|
|
|
|
(a)
|
|
The reasons described in reasonable detail in Part III of
this form could not be eliminated without unreasonable effort
or expense;
|
|
|
|
|
|
|
o
|
|
|
(b)
|
|
The subject annual report, semi-annual report, transition
report on Form 10-K, Form 20-F, Form 11-K, Form N-SAR, or
Form N-CSR or portion thereof will be filed on or before the
fifteenth calendar day following the prescribed due date; or
the subject quarterly report or transition report on Form
10-Q or subject distribution report on Form 10-D, or portion
thereof, will be filed on or before the fifth calendar day
following the prescribed due date; and
|
|
|
|
|
|
|
|
|
|
(c)
|
|
The accountants statement or other exhibit required by Rule
12b-25(c) has been attached if applicable.
|
PART III
NARRATIVE
State below in reasonable detail the reasons why Forms 10-K, 20-F, 11-K, 10-Q, N-SAR, N-CSR, or the
transition report or portion thereof, could not be filed within the prescribed time period.
|
|
MedQuist Holdings Inc. (the Company) was unable to file Amendment No. 1 to its Annual
Report on Form 10-K for the fiscal year ended December 31, 2010 (the Form 10-K) within the
prescribed period (on or before May 2, 2011) because of unanticipated delays in compiling
all of the information necessary to make the filing on or before May 2, 2011. The Company
subsequently filed Amendment No. 1 to the Form 10-K on May 3, 2011.
|
PART IV
OTHER INFORMATION
(1)
|
|
Name and telephone number of person to contact in regard to this notification:
|
|
|
|
|
|
Mark R. Sullivan
|
|
(856)
|
|
206-4210
|
|
|
|
|
|
(Name)
|
|
(Area Code)
|
|
(Telephone Number)
|
(2)
|
|
Have all other periodic reports required
under Section 13 or 15(d) of the Securities
Exchange Act of 1934 or Section 30 of the
Investment Company Act of 1940 during the
preceding 12 months or for such shorter
period that the registrant was required to
file such report(s) been filed? If the
answer is no, identify report(s).
þ
Yes
o
No
|
|
(3)
|
|
Is it anticipated
that any
significant change
in results of
operations from the
corresponding
period for the last
fiscal year will be
reflected by the
earnings statements
to be included in
the subject report
or portion thereof?
o
Yes
þ
No
|
If so, attach an explanation of the anticipated change, both narratively and quantitatively,
and, if appropriate, state the reasons why a reasonable estimate of the results cannot be made.
MedQuist Holdings Inc.
(Name of Registrant as Specified in Charter)
has caused this notification to be signed on its behalf by the undersigned thereunto duly authorized.
|
|
|
|
|
|
|
Date: May 3, 2011
|
|
By:
Name:
|
|
/s/ Mark R. Sullivan
Mark R. Sullivan
|
|
|
|
|
Title:
|
|
General Counsel, Chief Compliance Officer and
Secretary
|
|
|
Medx (CE) (USOTC:MEDH)
Historical Stock Chart
From Jun 2024 to Jul 2024
Medx (CE) (USOTC:MEDH)
Historical Stock Chart
From Jul 2023 to Jul 2024